Back to Research Library
Compound Profiles 10 min read

TB-500 Research Profile

Thymosin Beta-4 (TB-500) — exploring its role in actin regulation and tissue repair research.

Overview

TB-500 is a synthetic peptide derived from Thymosin Beta-4 (Tβ4), a 43-amino-acid protein present in nearly all human and animal cell types. The "TB-500" designation commonly refers to the biologically active actin-binding fragment of Tβ4, though both terms are used interchangeably across the research literature.

Thymosin Beta-4 was originally isolated from bovine thymus tissue in 1981. It has since been established as one of the most abundant intracellular peptides in mammalian biology and has attracted sustained research attention for its involvement in actin dynamics, vascular development, and tissue repair processes.

Molecular Biology

Actin Dynamics Regulation

The central molecular role of Tβ4 is to bind G-actin (monomeric actin) and regulate the availability of actin monomers for polymerisation into F-actin (filamentous form). This regulatory function is essential to:

  • •Cell structure and motility
  • •Wound edge closure through directed cell migration
  • •Immune cell function and activation
  • •Skeletal and cardiac muscle contraction

The specific peptide sequence driving this activity — Ac-LKKTETQ — is the fragment most relevant to TB-500 research applications.

Signalling Pathways

Unlike classical receptor-mediated peptides, Tβ4's extracellular effects are thought to occur through:

  • •Direct interaction with integrin receptors on the cell surface
  • •Engagement with PINCH protein (Particularly Interesting New Cysteine-Histidine rich protein)
  • •Modulation of ILK (Integrin-Linked Kinase) downstream signalling

Research Areas

Wound and Tissue Repair

Tβ4's involvement in wound healing represents one of the most thoroughly investigated areas. Studies have demonstrated:

  • •Re-epithelialisation: Stimulates directed keratinocyte migration across wound surfaces
  • •Angiogenesis: Promotes capillary formation to supply healing tissue with oxygen and nutrients
  • •Collagen production: Enhances collagen synthesis and deposition within healing wounds
  • •Inflammatory modulation: Reduces pro-inflammatory cytokine levels at wound sites

A notable study in the Annals of the New York Academy of Sciences showed that topical Tβ4 application significantly accelerated corneal wound healing in an animal model.

Cardiac Tissue Research

Emerging research in cardiac applications has generated considerable interest:

  • •Tβ4 may support the differentiation of epicardial progenitor cells into cardiomyocytes
  • •Mouse studies of myocardial infarction showed improved cardiac function with Tβ4 treatment
  • •Promotes angiogenesis in hypoxic cardiac tissue environments

Neurological Applications

Preliminary evidence suggests neuroprotective properties:

  • •Supports oligodendrocyte survival and developmental maturation
  • •May support remyelination in models of demyelinating conditions
  • •Stroke recovery models have shown improved neurological outcomes with Tβ4 treatment

Musculoskeletal Applications

TB-500 is commonly studied in musculoskeletal injury frameworks:

  • •Skeletal muscle: Promotes satellite cell activation and fibre regeneration
  • •Tendon tissue: Supports tenoblast proliferation and collagen deposition
  • •Bone: Preliminary evidence for modulation of osteoblast activity

Comparing TB-500 and BPC-157

Both compounds appear in research focused on tissue regeneration, but via different mechanisms:

| Feature | TB-500 (Tβ4) | BPC-157 | |---|---|---| | Primary mechanism | Actin modulation, PINCH/ILK | VEGF, nitric oxide pathway | | Biological origin | Endogenous mammalian peptide | Synthetic, gastric-derived | | Cardiac research | Substantial body of evidence | Limited | | GI research | Limited | Extensive | | Neurological evidence | Emerging | Dopamine/serotonin interaction |

Physical Properties

  • •Molecular Weight: 4963.5 Da (full Tβ4); ~1300 Da (active fragment)
  • •Active sequence: Ac-LKKTETQ
  • •Appearance: White lyophilised powder
  • •Solubility: Water soluble

Storage Recommendations

  • •Lyophilised: -20°C, shielded from light and moisture
  • •Reconstituted: 2–8°C for up to 4 weeks, or -20°C in aliquoted form

Key Literature Venues

Significant TB-500/Tβ4 research has been published in:

  • •Annals of the New York Academy of Sciences
  • •Nature Medicine
  • •Journal of Molecular and Cellular Cardiology
  • •FASEB Journal

This compound profile is for research and educational purposes only. TB-500 is not approved for human therapeutic use.

Research Use Only: All products are sold strictly for in-vitro laboratory research purposes. Not for human or veterinary consumption. Not approved by the MHRA for any therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease. Purchaser must be 18+ and a qualified researcher.

King Pharma

King Pharma is a UK-based supplier of independently verified, laboratory-grade peptide research compounds. All products are supplied for qualified scientific research use only.

⚠️ None of our products are intended for human use. No medicinal claims are made or implied.

© 2026 King Pharma Ltd. All rights reserved. Registered in England & Wales.

Secure payments:
VISAMCAMEXMaestro